We hereby consent to the inclusion in this Offering Statement on Form 1-A of our report dated June 04, 2024, with respect to the consolidated balance sheets of Med-X Inc. as of December 31, 2023, and 2022, and the related consolidated statements of operations, changes in stockholders’ equity and cash flows for the years ended December 31, 2023 and 2022 and the related notes to the consolidated financial statements, which report appears in the Offering Circular that is a part of this Offering Statement. Our opinion does not cover any subsequent events from the date of our report i.e. June 04, 2024, till the date of this letter that might have an impact on the financial statements and the fact has been disclosed in Footnote 16 – Unaudited Subsequent Events to the financial statements.
SetApart Accountancy Corp
October 11, 2024
Los Angeles, California
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.
